<DOC>
	<DOC>NCT00648999</DOC>
	<brief_summary>To demonstrate that patients treated with Kaletra have an improvement in their quality of life compared to the quality of life they had with their previous NRTI therapy.</brief_summary>
	<brief_title>Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>HIV Infected subjects Subjects failing in current HIV treatment, or Subjects with a viral load &lt; 400 copies/mL and not tolerating their current HIV treatment. Subject is currently participating in another clinical study or has participated in another clinical study within 30 days prior to screening visit Subject is pregnant</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Kaletra</keyword>
</DOC>